|
TMED2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67298000000038E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.577030E-04 |
| Normal-vs-Stage2 |
1.238070E-02 |
| Normal-vs-Stage3 |
1.70730000026431E-07 |
| Normal-vs-Stage4 |
4.3859000000035E-05 |
| Stage1-vs-Stage2 |
6.544600E-01 |
| Stage1-vs-Stage3 |
4.607900E-02 |
| Stage1-vs-Stage4 |
1.910380E-01 |
| Stage2-vs-Stage3 |
8.346400E-02 |
| Stage2-vs-Stage4 |
1.817210E-01 |
| Stage3-vs-Stage4 |
9.564200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28930000001348E-06 |
| Normal-vs-AfricanAmerican |
9.378400E-02 |
| Normal-vs-Asian |
8.44490000040388E-07 |
| Caucasian-vs-AfricanAmerican |
2.076000E-01 |
| Caucasian-vs-Asian |
1.448430E-01 |
| AfricanAmerican-vs-Asian |
8.979800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.54879999999724E-05 |
| Normal-vs-Female |
3.73810000000585E-05 |
| Male-vs-Female |
6.615000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.824670E-04 |
| Normal-vs-Age(41-60Yrs) |
1.73263999999618E-05 |
| Normal-vs-Age(61-80Yrs) |
7.59220000000616E-05 |
| Normal-vs-Age(81-100Yrs) |
1.521570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.015800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.416200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.422400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.176600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.784200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.017800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.161800E-02 |
| Classical-VS-Follicular |
3.085600E-01 |
| Classical-VS-Other |
1.500390E-01 |
| Classical-VS-Normal |
2.07009999999563E-05 |
| Tall-VS-Follicular |
1.286200E-02 |
| Tall-VS-Other |
4.463800E-01 |
| Tall-VS-Normal |
4.84279999990456E-07 |
| Follicular-VS-Other |
1.662450E-01 |
| Follicular-VS-Normal |
1.423570E-02 |
| Other-VS-Normal |
2.942900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.201500E-04 |
| Normal-vs-N1 |
5.31949999604819E-08 |
| N0-vs-N1 |
6.903700E-03 |
|
|
